CD22 CAR T-Cells Manufactured in Prodigy System and in Bag Culture Yield Equivalent Responses for B-ALL
Alexandra Dreyzin(National Cancer Institute), Nirali N. Shah(National Institutes of Health), Kara L. Davis(Stanford Medicine), Sneha Ramakrishna(Stanford University), Constance M. Yuan(National Cancer Institute), Grégoire Altan‐Bonnet(National Cancer Institute), Naomi Taylor(National Institutes of Health), Matthew J. Frank(Stanford Blood Center), Steven A. Feldman(Stanford University), Bonnie Yates(National Institutes of Health), Kathryn R. Martin(University of Aberdeen), Crystal L. Mackall(Stanford University), Liora M. Schultz(Stanford Medicine), Anne Marijn Kramer(Stanford Blood Center), Bita Sahaf(Stanford University), Haneen Shalabi(Center for Cancer Research), David F. Stroncek(Yale University), Zachary Ehlinger(Cancer Prevention Institute of California), Hao‐Wei Wang(Fu Jen Catholic University), Lori Muffly(Stanford University), Sunita Patil(Cancer Prevention Institute of California), Steven L. Highfill(National Institutes of Health)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
The History and Future of the Fluorescence Activated Cell Sorter and Flow Cytometry: A View from Stanford
|Clinical Chemistry|2002|605